Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Pediatric Transplants

Reduced-intensity conditioning hematopoietic SCT for pediatric patients with LAD-1: clinical efficacy and importance of chimerism

Bone Marrow Transplantation volume 47, pages 646–650 (2012)Cite this article

Abstract

Pediatric patients with leukocyte adhesion deficiency type-I (LAD-I) experience severe and recurrent life-threatening bacterial infections with failure of pus formation and delayed wound healing. LAD-I is a rare inherited disease caused by mutation in the leukocyte CD18 integrin expression, resulting in defective adherence and migration of leukocytes, in particular neutrophilic granulocytes through the intravascular space. Hematopoietic SCT is the only curative treatment option available to patients with LAD-I. Since 2007, in a prospective trial, reduced-intensity conditioning regimen have been developed for 10 consecutive patients with LAD-I who were referred to our center. Based upon available data, it is the first time that such a number of patients affected by LAD-I have been treated with this regimen. This study attempts to show that reduced-intensity regimen leads to a favorable result in LAD-I patients even in those who have experienced comorbid complications. Following transplantation, some patients develop mixed chimerism, however, in our study mixed chimerism was not followed by transplant rejection.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Hayward AR, Harvey BA, Leonard J, Greenwood MC, Wood CB, Soothill JF . Delayed separation of the umbilical cord, widespread infections, and defective neutrophil mobility. Lancet 1979; 1: 1099–1101.

    Article  CAS  Google Scholar 

  2. Qasim W, Cavazzana-Calvo M, Davies EG, Davis JM, Eames G et al. Allogeneic hematopoietic stem-cell transplantation for leukocyte adhesion deficiency. Pediatrics 2009; 123: 836–840.

    Article  Google Scholar 

  3. Le Deist F, Blanche S, Keable H, Gaud C, Pham H, Descamp-Latscha B et al. Successful HLA nonidentical bone marrow transplantation in three patients with the leukocyte adhesion deficiency. Blood 1989; 74: 512–516.

    CAS  PubMed  Google Scholar 

  4. Thomas C, Le Deist F, Cavazzana-Calvo M, Benkerrou M, Haddad E, Blanche S et al. Results of allogeneic bone marrow transplantation in patients with leukocyte adhesion deficiency. Blood 1995; 86: 1629–1635.

    CAS  PubMed  Google Scholar 

  5. Bauer Jr TR, Creevy KE, Gu YC, Tuschong LM, Donahue RE, Metzger ME et al. Very low levels of donor CD18+ neutrophils following allogeneic hematopoietic stem cell transplantation reverse the disease phenotype in canine leukocyte adhesion deficiency. Blood 2004; 103: 3582–3589.

    Article  CAS  Google Scholar 

  6. Al-wahadneh AM, Haddadin I, Hamouri M, Omari K, Aejellat F . Bone marrow transplantation for leukocyte adhesion deficiency-I: case report. Saudi J Kidney Dis Transpl 2006; 17: 564–567.

    PubMed  Google Scholar 

  7. Fischer A, Landais P, Friedrich W, Gerritsen B, Fasth A, Porta F et al. Bone marrow transplantation (BMT) in Europe for primary immunodeficiencies other than severe combined immunodeficiency: a report from the European Group for BMT and the European Group for Immunodeficiency. Blood 1994; 83: 1149–1154.

    CAS  PubMed  Google Scholar 

  8. Burkholder TH, Colenda L, Tuschong LM, Starost MF, Bauer Jr TR, Hickstein DD . Reproductive capability in dogs with canine leukocyte adhesion deficiency treated with nonmyeloablative conditioning prior to allogeneic hematopoietic stem cell transplantation. Blood 2006; 108: 1767–1769.

    Article  CAS  Google Scholar 

  9. Sokolic RA, Bauer TR, Gu YC, Hai M, Tuschong LM, Burkholder T et al. Nonmyeloablative conditioning with busulfan before matched littermate bone marrow transplantation results in reversal of the disease phenotype in canine leukocyte adhesion deficiency. Biol Blood Marrow Transplant 2005; 11: 755–763.

    Article  CAS  Google Scholar 

  10. Hamidieh AA, Pourpak Z, Alimoghaddam K, Movahedi M, Bahoush G, Behmanesh F et al. Successful allogeneic stem cell transplantation with a reduced-intensity conditioning in a leukocyte adhesion deficiency type I patient. Pediatr Transplant 2009; 15: E30–E33.

    Google Scholar 

  11. Bauer Jr TR, Gu YC, Tuschong LM, Burkholder T, Bacher JD, Starost MF et al. Nonmyeloablative hematopoietic stem cell transplantation corrects the disease phenotype in the canine model of leukocyte adhesion deficiency. Exp Hematol 2005; 33: 706–712.

    Article  CAS  Google Scholar 

  12. Creevy KE, Bauer Jr TR, Tuschong LM, Embree LJ, Silverstone AM, Bacher JD et al. Mixed chimeric hematopoietic stem cell transplant reverses the disease phenotype in canine leukocyte adhesion deficiency. Vet Immunol Immunopathol 2003; 95: 113–121.

    Article  CAS  Google Scholar 

  13. Mancias C, Infante AJ, Kamani NR . Matched unrelated donor bone marrow transplantation in leukocyte adhesion deficiency. Bone Marrow Transplant 1999; 24: 1261–1263.

    Article  CAS  Google Scholar 

  14. Takahashi D, Nagatoshi Y, Saito Y, Inagaki J, Nagayama J, Shinkoda Y et al. Unrelated bone marrow transplantation using a reduced intensity-conditioning regimen in leukocyte adhesion deficiency. Bone Marrow Transplant 2006; 37: 807–808.

    Article  CAS  Google Scholar 

  15. Gu YC, Bauer TR, Sokolic RA, Hai M, Tuschong LM, Burkholder T et al. Conversion of the severe to the moderate disease phenotype with donor leukocyte microchimerism in canine leukocyte adhesion deficiency. Bone Marrow Transplant 2006; 37: 607–614.

    Article  Google Scholar 

  16. Engel ME, Hickstein DD, Bauer Jr TR, Calder C, Manes B, Frangoul H . Matched unrelated bone marrow transplantation with reduced-intensity conditioning for leukocyte adhesion deficiency. Bone Marrow Transplant 2006; 37: 717–718.

    Article  CAS  Google Scholar 

  17. Farinha NJ, Duval M, Wagner E, Champagne J, Lapointe N, Barrette S et al. Unrelated bone marrow transplantation for leukocyte adhesion deficiency. Bone Marrow Transplant 2002; 30: 979–981.

    Article  CAS  Google Scholar 

  18. Ozyurek E, Cowan MJ, Koerper MA, Baxter-Lowe LA, Dvorak CC, Horn BN . Increasing mixed chimerism and the risk of graft loss in children undergoing allogeneic hematopoietic stem cell transplantation for non-malignant disorders. Bone Marrow Transplant 2008; 42: 83–91.

    Article  CAS  Google Scholar 

  19. Liesveld JL, Rothberg PG . Mixed chimerism in SCT: conflict or peaceful coexistence? Bone Marrow Transplant 2008; 42: 297–310.

    Article  CAS  Google Scholar 

  20. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295–304.

    Article  CAS  Google Scholar 

  21. Shulman HM, Sale GE, Lerner KG, Barker EA, Weiden PL, Sullivan K et al. Chronic cutaneous graft-versus-host disease in man. Am J Pathol 1978; 91: 545–570.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank Dr Mohammad reza Ostadali, and we acknowledge the patients who participated in this study, the Hematology-Oncology and Stem Cell Transplantation Research Centre nursing staff and the referring doctors.

Author information

Authors and Affiliations

  1. Hematology, Oncology and Stem Cell Transplantation Research Centre, Tehran University of Medical Sciences, Tehran, Iran

    A A Hamidieh, M Hosseinzadeh, K Alimoghaddam, A Hosseini, M Jalili & A Ghavamzadeh

  2. Immunology, Asthma & Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran

    Z Pourpak, M R Fazlollahi, M Movahedi & M Moin

  3. Department of Pediatrics & Clinical Immunology, Mofid Children Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Z Chavoshzadeh

  4. Department of Pediatrics & Clinical Immunology, Rasoul-e-Akram Hospital, Tehran University of Medical Sciences, Tehran, Iran

    S Arshi

Authors
  1. A A Hamidieh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Z Pourpak
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Hosseinzadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M R Fazlollahi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K Alimoghaddam
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M Movahedi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A Hosseini
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Z Chavoshzadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. M Jalili
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. S Arshi
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. M Moin
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. A Ghavamzadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A A Hamidieh.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hamidieh, A., Pourpak, Z., Hosseinzadeh, M. et al. Reduced-intensity conditioning hematopoietic SCT for pediatric patients with LAD-1: clinical efficacy and importance of chimerism. Bone Marrow Transplant 47, 646–650 (2012). https://doi.org/10.1038/bmt.2011.140

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2011.140

Keywords

This article is cited by

Search

Advanced search

Quick links